Last updated 04.10.2026
Last updated 04.10.2026
RWIN
| 1-MO | 3-MO | 1Y | 3Y | 5Y | YTD | Since Inception (04.07.2026) | |
|---|---|---|---|---|---|---|---|
| RWIN NAV (%) | – | – | – | – | – | – | – |
| RWIN Market Price (%) | – | – | – | – | – | – | – |
The Fund is newly formed and has no operating history. The performance quoted represents past performance and does not guarantee future results. Performance for periods greater than 1 year is annualized. Investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than the original cost.
Current performance may be lower or higher than the performance quoted.
Shares are bought and sold at market price (not NAV) and are not individually redeemed from the Fund. The returns shown do not represent the returns you would receive if you traded shares at other times. Brokerage commissions will reduce returns. The market price returns are based on the official closing price of an ETF share or, if the official closing price isn't available, the midpoint between the national best bid and national best offer (“NBBO”) as of the time the ETF calculates current NAV per share. NAVs are calculated using prices as of 4:00 PM Eastern Time.
NAV Return represents the closing price of underlying securities.
Market Return is calculated using the price which investors buy and sell ETF shares in the market. The market returns in the table are based upon the midpoint of the bid/ask spread at 4:00 pm EST, and do not represent the returns you would have received if you traded shares at other times.
NAV
$25.91 Net Asset Value
NAV Change
+$0.06
Price
$25.96
Price Change
+$0.06
| Inception Date | 04.07.2026 |
| Ticker | RWIN |
| Primary Exchange | NASDAQ |
| Total Annual Fund Operating Expense* | 0.42% |
| CUSIP | 754640308 |
| Premium/Discount | 0.00% |
| 30-Day Median Bid/Ask Spread ¹ | – |
¹ 30-Day Median Bid/Ask Spread: The spread is calculated by identifying the ETF’s national best bid and national best offer ("NBBO") as of the end of each 10 second interval during each trading day of the last 30 calendar days and dividing the difference between each such bid and offer by the midpoint of the NBBO.
The median of those values is identified and that value is expressed as a percentage rounded to the nearest hundredth.
* A full explanation of expenses and fees are stated in the prospectus.
The Rayliant NxtGen Multifactor International Equity ETF (the “Fund”) seeks long-term capital appreciation.
|
Number of Days At |
2026 Q2 |
|---|---|
| Premium | 3 |
| NAV | 1 |
| Discount | 0 |
The Premium/Discount History chart demonstrates the difference between the daily market
price of shares of the Fund and the Fund’s net asset value (NAV).
The vertical axis of
the chart shows the premium or discount of the daily market price as a percentage of the
NAV. The horizontal axis shows each trading day in the time period, and each data point in
the chart represents the Premium/Discount on that day. The data presented in the chart and
table above represent past performance and cannot be used to predict future results.
(as of 04.10.2026) Holdings are subject to change.
| Ticker | Company Name | % of Net Assets |
|---|---|---|
| ROP SW | Roche Holding A.G. | 2.92% |
| 6857 JP | Advantest Corporation | 2.42% |
| CS FP | AXA S.A. | 2.19% |
| ALV GR | Allianz S.E. | 1.94% |
| ASML NA | ASML Holding N.V. | 1.92% |
| SAF FP | Safran S.A. | 1.72% |
| DANSKE DC | Danske Bank A/S | 1.59% |
| SAN FP | Sanofi S.A. | 1.52% |
| IMB LN | Imperial Brands plc | 1.48% |
| GALD SW | Galderma Group A.G. | 1.44% |